Speaker Profile
Co-Founder & CEO, Omniscope
Biography
Vijay Vaswani views science as fundamental to humanity. He has been part of scaling companies such as Illumina and 10X Genomics. He has acquired and commercialized disruptive diagnostic technologies during his leadership at Siemens Healthineers and Meridian Biosciences. Vijay has been part of important IPOs in the biotechnology industry and finds his passion in improving health through the application of technology.
Talk
AI-Enabled Immune Repertoire Modeling to Identify Response to Immunotherapy
Despite efficacy of immunotherapy, only 20% of patients respond, thus highly heterogeneous patient responses highlight the need for novel predictive strategies that leverage immune cell biomarkers to stratify patients for ICI therapy. Omniscope's deep immune repertoire sequencing and AI demonstrate potential clinical utility.
Clinical Dx Showcase:
Omniscope
Omniscope is a Deep Biotech whose technology platforms decode the immune system in high resolution to inform therapy and develop diagnostics through the convergence of immune cell sequencing and artificial intelligence.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Neurodegenerative
